A coating applied to endotracheal tubes can release antimicrobial peptides that target infectious bacteria and reduce upper-airway bacterial inflammation during intubation.
The NIH updated its COVID-19 Treatment Guidelines with new information following the FDA emergency use authorization of baricitinib.Read More
Siemens Healthineers signed a US distribution agreement for CorVent Medical’s Respond-19 Ventilator, which received FDA authorization earlier this month.Read More
A study of obese patients hospitalized for COVID-19 found that these patients had higher odds for invasive mechanical ventilation and mortality compared to normal BMI COVID-19 patients.Read More
The global ventilator market was worth $2.54 billion in 2019 and is expected to reach $9.13 billion by the end of 2027.Read More
COVID-19 has forced many severely ill patients to undergo mechanical ventilation for extended durations, an intervention that can increase their risks of other hospital-acquired infections such as ventilator-associated pneumonia (VAP).Read More
COVID-19 patients who were administered intravenous immunoglobulin (IVIG) therapy were less likely to be intubated and had a shorter hospital length of stay compared to standard care.Read More